Sherwin-Williams — Apr 28, 2026 release

Against a challenging prior year comparison, SG&A increased by a mid-single digit percentage, excluding the expected headwinds from Suvinil, non-annualized operating costs and depreciation related to our new buildings and foreign currency translation. Our expectation of a low-single digit percentage increase in SG&A for the full year remains unchanged. Net income, adjusted earnings per share and EBITDA all increased over the prior year quarter. Our global team continues to execute our strategy, delivering reliability and consistency for our customers while focusing on what we can control.” 1 FIRST QUARTER CONSOLIDATED RESULTS (in millions, except per share data) Three Months Ended March 31, 2026 2025 $ Change % Change Net sales $ 5,666.9 $ 5,305.7 $ 361.2  6.8  % Income before income taxes $ 679.8 $ 653.0 $ 26.8  4.1  % Percent to Net sales 12.0% 12.3% Net income per share - diluted $ 2.15 $ 2.00 $ 0.15  7.5  % Adjusted net income per share - diluted $ 2.35 $ 2.25 $ 0.10  4.4  % Consolidated Net sales increased primarily due to higher Net sales in all reportable segments, inclusive of the October 2025 acquisition of Suvinil and a 1.7% impact from favorable foreign currency translation. Income before income taxes increased primarily due to higher Net sales and moderating raw material costs, partially offset by an increase in employee-related and marketing costs to support higher Net sales, incremental selling, general and administrative (SG&A) expenses associated with Suvinil and highe